The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.


AGY  ALLERGY THERAPEUTICS PLC  ORD 0.1P

ALLERGY THERA.  Currency GBX 
Company




 Page 1 of 2

| 1 | 2 | Next

Time/Date Code Headline Source Impact
10:20 15-May-2013 AGY Grant of Options RNS -0.49% Down
10:39 08-May-2013 AGY Holding(s) in Company RNS +0.49% Up
10:18 08-May-2013 AGY Holding(s) in Company RNS +0.49% Up
07:00 25-Mar-2013 AGY Half Yearly Report RNS +3.08% Up
07:00 11-Mar-2013 AGY US patent granted RNS +4.40% Up
07:00 11-Mar-2013 AGY Notice of results and shareholder update RNS +4.40% Up
09:00 01-Feb-2013 AGY Total Voting Rights RNS -5.83% Down
10:41 22-Jan-2013 AGY Exercise of Options RNS -3.49% Down
07:00 28-Dec-2012 AGY Total Voting Rights RNS -2.50% Down
12:02 27-Dec-2012 AGY Update on Lincoln Medical Final RNS -2.31% Down
15:14 19-Dec-2012 AGY Grant of Options RNS -3.69% Down
11:44 10-Dec-2012 AGY Director/PDMR Shareholding RNS -2.36% Down
15:42 05-Dec-2012 AGY Total Voting Rights RNS -1.18% Down
12:40 04-Dec-2012 AGY Exercise of Options RNS -0.98% Down
09:00 30-Nov-2012 AGY Total Voting Rights RNS -0.78% Down
14:23 21-Nov-2012 AGY Holding(s) in Company RNS -1.14% Down
14:25 20-Nov-2012 AGY Exercise of Options RNS -0.76% Down
11:41 14-Nov-2012 AGY Result of AGM RNS +0.38% Up
12:12 09-Nov-2012 AGY Director/PDMR Shareholding RNS +0.58% Up
15:54 16-Oct-2012 AGY Annual Financial Report RNS +1.46% Up

 Page 1 of 2

| 1 | 2 | Next


ALLERGY THERA. - News Analysis

space
space

The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds.

You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.

The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds